Invasive Fungal Sinusitis following Liver or Bone Marrow Transplantation

Invasive fungal infection of the nose and paranasal sinuses occurs almost exclusively in immunocompromised patients and is increasingly recognized as a complication of organ transplantation. We performed a retrospective chart review of 955 bone marrow and 749 liver transplant patients to identify risk factors, presenting signs and symptoms, methods of diagnosis, and successful management strategies. We report on five cases following bone marrow transplantation and one case following liver transplantation. Neutropenia is the single most important risk factor in the development of and recovery from invasive fungal sinusitis. Early diagnosis, combined with antifungal agents, hematopoietic growth factors, and aggressive surgical debridement is the most effective means of management.

[1]  J. Nemunaitis,et al.  Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. , 1991, Blood.

[2]  J. Armitage,et al.  Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. , 1991, The New England journal of medicine.

[3]  R. Stratta,et al.  Clinical spectrum of fungal infections after orthotopic liver transplantation. , 1991, Archives of surgery.

[4]  J. Corey,et al.  Fungal Diseases of the Sinuses , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[5]  J. Salisbury,et al.  Fulminant fungal sinusitis following intensive chemotherapy. , 1990, The Quarterly journal of medicine.

[6]  S. Jagannath,et al.  Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. Weisdorf,et al.  Aggressive combined modality treatment of progressive sinonasal fungal infections in immunocompromised patients. , 1988, The American journal of medicine.

[8]  D. Kennedy,et al.  Chronic Fungal Sinusitis in Apparently Normal Hosts , 1988, Medicine.

[9]  R. Hackman,et al.  Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature , 1986, Cancer.

[10]  H. Fuchs,et al.  Invasive aspergillosis of the sphenoid sinus manifested as a pituitary tumor. , 1985, Southern medical journal.

[11]  D. Shedd,et al.  Aspergillosis of the nose and paranasal sinuses in neutropenic patients at an oncology center. , 1985, Head & neck surgery.

[12]  N. Berlinger.  Sinusitis in immunodeficient and immunosuppressed patients , 1985, The Laryngoscope.

[13]  W. Wilson,et al.  Fungal sinusitis in healthy and immunocompromised individuals. , 1984, American journal of clinical pathology.

[14]  C. Stratton,et al.  Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. , 1983, The Journal of infectious diseases.

[15]  R. Berkow,et al.  Invasive aspergillosis of paranasal tissues in children with malignancies. , 1983, The Journal of pediatrics.

[16]  D. Armstrong,et al.  Invasive Aspergillosis: Progress in early diagnosis and treatment , 1981 .

[17]  G. Healy,et al.  Fulminant aspergillosis of the nose and paranasal sinuses: A new clinical entity , 1980, The Laryngoscope.

[18]  J. Aisner,et al.  Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. , 1977, Annals of internal medicine.

[19]  E. Stinson,et al.  Aspergillus infection complicating cardiac transplantation. Report of five cases. , 1971, Archives of internal medicine.